Hallucinogenic mushrooms may hold the key to treating anxiety, depression in cancer patients

Researchers might be closing in on a far-out approach to treating anxiety and depression in cancer patients. Two new studies released Thursday indicate that just one dose of psilocybin, a substance found only in hallucinogenic mushrooms, could immediately cut anxiety and depression in cancer patients for as long as eight months.
Two separate trials, the results of which were both published in the Journal of Psychopharmacology, found side effects of the drug to be "minimal," and results to be apparent in about "about 80 percent" of patients, The New York Times reported. "In spite of their unique vulnerability and the mood disruption that the illness and contemplation of their death has prompted, these participants have the same kind of experiences, that are deeply meaningful, spiritually significant, and producing enduring positive changes in life and mood and behavior," said Professor Roland Griffiths, who led the study at the Johns Hopkins University School of Medicine.
Psilocybin, along with other hallucinogens, has been classified as a Schedule 1 drug in the U.S. for more than 40 years. Though these studies' findings were hailed as "the most profound to date in the medical use of psilocybin," scientists say much more research must be done.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
The state of Britain's Armed Forces
The Explainer Geopolitical unrest and the unreliability of the Trump administration have led to a frantic re-evaluation of the UK's military capabilities
By The Week UK
-
Anti-anxiety drug has a not-too-surprising effect on fish
Under the radar The fish act bolder and riskier
By Devika Rao, The Week US
-
Sudoku medium: April 21, 2025
The Week's daily medium sudoku puzzle
By The Week Staff
-
China accuses NSA of Winter Games cyberattacks
speed read China alleges that the U.S. National Security Agency launched cyberattacks during the Asian Winter Games in February
By Rafi Schwartz, The Week US
-
Russian strike kills dozens in Ukraine
Speed Read The Sumy ballistic missile strike was Russia's deadliest attack on civilians this year
By Peter Weber, The Week US
-
Inside the Israel-Turkey geopolitical dance across Syria
THE EXPLAINER As Syria struggles in the wake of the Assad regime's collapse, its neighbors are carefully coordinating to avoid potential military confrontations
By Rafi Schwartz, The Week US
-
South Korea court removes impeached president
Speed Read The Constitutional Court upheld the impeachment of Yoon Suk Yeol after his declaration of martial law in December
By Peter Weber, The Week US
-
Myanmar quake deaths rise as survivor search intensifies
speed read The magnitude-7.7 earthquake in central Myanmar has killed a documented 2,000 people so far, and left scores more trapped beneath rubble
By Peter Weber, The Week US
-
'Like a sound from hell': Serbia and sonic weapons
The Explainer Half a million people sign petition alleging Serbian police used an illegal 'sound cannon' to disrupt anti-government protests
By Abby Wilson
-
Israel detains director after West Bank settler clash
speed read The director of Oscar-winning documentary 'No Other Land' was arrested and beaten
By Rafi Schwartz, The Week US
-
Turkey arrests Istanbul mayor, a top Erdogan rival
Speed Read Protests erupted in Turkey after authorities detained Istanbul Mayor Ekrem Imamoglu
By Peter Weber, The Week US